Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is threatening public health. A large number of …

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and has infected over 200 million people, causing over 4 million deaths. COVID-19 infection …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Hundreds of millions of SARS-CoV-2 mRNA-LNP vaccine doses have already been
administered to humans. However, we lack a comprehensive understanding of the immune …

Abstract As of 25th July, 2022, global Disease burden of 575,430,244 confirmed cases and
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …

Invasive fungal disease (IFD) associated with Coronavirus Disease 2019 (COVID-19) has
focussed predominantly on invasive pulmonary aspergillosis. However, increasingly …

The physiopathologic characteristics of COVID-19 (high levels of inflammatory cytokines and
T-cell reduction) promote fungal colonization and infection, which can go unnoticed because …

Four types of antifungal drugs are available that include inhibitors of ergosterol synthesis, of
fungal RNA biosynthesis, and of cell wall biosynthesis as well as physiochemical regulators …

Being considered minor vexations, fungal infections hinder the life of about 15% of the world
population superficially, with rare threats to life in case of invasive sepsis. A significant rise in …

Studies demonstrated the impact of the COVID-19 pandemic in the prevalence and
susceptibility profiles of bacterial and fungal organisms. We analyzed 4821 invasive fungal …